Judge Admits Expert Opining On ‘First-Mover Advantage’ In Drug Patent Case
SAN FRANCISCO — A California federal judge on June 8 denied a pharmaceutical company’s motion to exclude a competitor’s expert witness in a patent infringement case, finding that the expert met...To view the full article, register now.
Already a subscriber? Click here to view full article